
Enzolytics, Inc., which is rolling out its over-the-counter IPF Immune™ health supplement, is committed to developing effective and affordable therapeutics for treating infectious diseases. Leading Enzolytics, Inc. is Charles S. Cotropia, who previously served as CEO of BioClonetics Immunotherapeutics, Inc. since 2009, before BioClonetics merged with Enzolytics. “I have a bachelor’s degree in Aerospace Engineering from… Read more »